Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 Alterations

NCT06581432 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

430

Enrollment

INDUSTRY

Sponsor class

Conditions

Solid Tumours

Interventions

DRUG: Zongertinib

Sponsor

Boehringer Ingelheim